EGFR and non-small cell lung carcinoma: The focus on genetic alterations may not fully explain the fact that some NSCLC patients have diverse responses to EGFR-TKIs even if they bear the same EGFR sensitive driver oncogenes and do not concurrently have other resistance-leading mutations4.